In order to prove that early STAT1 inhibition is sufficient to block the TI protective phenotype, and not just downstream markers, we repeated the inhibitor regime with control or trained mice receiving either Fedratinib or DMSO, with or without S.Tm infection after 2 weeks (Figure 4A). The gene discussed is STAT1; the disease is infection.